Bringing hormone testing beyond the lab, wherever and whenever it’s needed.
Misslaboratory brings quantitative hormone testing beyond the lab-wherever and whenever patients and clinicians need it.
We will generate revenue through disposable hormone test strips, portable reader sales or leasing, and software subscriptions.
Hormone monitoring requires repeated clinic visits and blood draws, with delayed results adding burdens for patients and clinicians.
Working progesterone sensor developed; next: integrated prototype, pilot manufacturing, clinical validation and regulatory approval.
Portable finger-prick hormone testing to reduce clinic visits, waiting times and patient burden while supporting clinical decisions.
Alternatives include lab tests, urine/saliva kits and wearables. We combine portable blood-based testing with quantitative hormone results.
A portable reader and disposable strips for quantitative hormone testing from finger-prick blood, starting with progesterone.
With or without investment — figures provided by the founders.
We are seeking €2 million to expand our team, integrate our portable hormone-testing platform, establish pilot manufacturing and advance clinical validation and regulatory readiness. We also welcome clinical partners, medtech investors and manufacturing experts.
We combine finger-prick blood sampling, on-strip plasma separation and quantitative hormone sensing in one portable platform.
We serve patients through clinicians via a B2B2C model, initially targeting fertility clinics and hormone-care providers.
We plan to sell readers and disposable strips through fertility clinics and hormone-care providers, supported by software subscriptions.
2B tests a year/40B value market.
Clinician webinars, IVF patient communities, clinic pilot programmes and LinkedIn outreach to fertility specialists and clinic directors.
